Harvest Fund Management’s Haemonetics HAE Stock Holding History

Harvest Fund Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-574	Closed	-$51K	–	663
2023 Q3	$51K	Sell	574 -1,837	-76%	-$164K	0.01%	402
2023 Q2	$205K	Buy	2,411 +1,062	+79%	+$89.8K	0.04%	197
2023 Q1	$112K	Buy	1,349 +877	+186%	+$71K	0.02%	304
2022 Q4	$37K	Hold	472	–	–	0.01%	514
2022 Q3	$35K	Buy	+472	New	+$33.9K	0.01%	471
2020 Q1	–	Sell	-256	Closed	-$12K	–	436
2019 Q4	$12K	Sell	256 -957	-79%	-$116K	﹤0.01%	390
2019 Q3	$153K	Buy	1,213 +864	+248%	+$110K	0.02%	151
2019 Q2	$42K	Buy	+349	New	+$34.3K	0.01%	310
2019 Q1	–	Sell	-2,929	Closed	-$293K	–	371
2018 Q4	$293K	Sell	2,929 -2,046	-41%	-$215K	0.06%	78
2018 Q3	$570K	Buy	+4,975	New	+$515K	0.1%	55

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harvest Fund Management's HAE Position: Q4 2023 in Review

Harvest Fund Management sold out of Haemonetics (HAE) in Q4 2023, closing a stake of 574 shares — an estimated $51K sold.

Harvest Fund Management first reported a position in HAE in Q3 2018 and held it in 10 quarters. The position peaked at $570K in Q3 2018. 295 funds tracked by Wall St. Rank hold HAE as of Q4 2023.

Harvest Fund Management reported no remaining Haemonetics position as of Q4 2023 after selling out during the quarter.
Harvest Fund Management sold 574 Haemonetics shares in Q4 2023, an estimated $51K.
Harvest Fund Management first reported a position in Haemonetics in Q3 2018 and held it in 10 quarters.
Harvest Fund Management's Haemonetics position peaked at $570K in Q3 2018.
295 funds tracked by Wall St. Rank held Haemonetics as of Q4 2023.

Based on Harvest Fund Management's 13F filing for Q4 2023, filed 2 Feb 2024.